Literature DB >> 16837776

Overexpression of polo-like kinase 1 (PLK1) and chromosomal instability in bladder cancer.

Yoshiaki Yamamoto1, Hideyasu Matsuyama, Shigeto Kawauchi, Hiroaki Matsumoto, Kazuhiro Nagao, Chietaka Ohmi, Shigeru Sakano, Tomoko Furuya, Atsunori Oga, Katsusuke Naito, Kohsuke Sasaki.   

Abstract

Polo-like kinase 1 (PLK1) participates in bipolar spindle formation and entry into mitosis. Chromosomal instability (CIN) is caused by abnormalities in spindle formation and chromosome segregation. In this study, we investigated the relationship of PLK1 overexpression to CIN, and compared the PLK1 status with clinicopathological parameters in 101 human urothelial carcinomas of the urinary bladder. Expression of PLK1 and the number of centrosomes were assessed by immunohistochemistry. Numerical aberrations of chromosomes 7, 9 and 17 spots that allowed estimation of CIN were evaluated by fluorescence in situ hybridization, and DNA ploidy was assessed by laser scanning cytometry. Cancers with a large intercellular variation in centromere copy number were defined as CIN cancers. Tumors with PLK1 overexpression were associated more frequently with CIN (p < 0.0001), DNA aneuploidy (p = 0.0007) and centrosome amplification (p = 0.0013) than those without. Overexpression of PLK1 was significantly related to higher pathological grade (p = 0.0024), multiple tumors (p = 0.0241) and positive urine cytology (p = 0.0192). These data suggest that a high level expression of PLK1 confers tumor progression advantages to urothelial cancer cells, although other factors are also involved. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16837776     DOI: 10.1159/000094416

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  36 in total

Review 1.  Muscle-invasive urothelial bladder cancer: an update on systemic therapy.

Authors:  Hayley Knollman; J Luke Godwin; Rishi Jain; Yu-Ning Wong; Elizabeth R Plimack; Daniel M Geynisman
Journal:  Ther Adv Urol       Date:  2015-12

2.  Non-visual arrestins are constitutively associated with the centrosome and regulate centrosome function.

Authors:  Haripriya Shankar; Allison Michal; Ronald C Kern; Dong Soo Kang; Vsevolod V Gurevich; Jeffrey L Benovic
Journal:  J Biol Chem       Date:  2010-01-07       Impact factor: 5.157

3.  Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.

Authors:  Chunling Zhao; Lei Gong; Wentong Li; Limei Chen
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

Review 4.  Cdk1, Plks, Auroras, and Neks: the mitotic bodyguards.

Authors:  Patrick Salaun; Yoann Rannou; Claude Prigent
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 5.  Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy.

Authors:  Klaus Strebhardt
Journal:  Nat Rev Drug Discov       Date:  2010-08       Impact factor: 84.694

6.  Interaction of Sororin protein with polo-like kinase 1 mediates resolution of chromosomal arm cohesion.

Authors:  Nenggang Zhang; Anil K Panigrahi; Qilong Mao; Debananda Pati
Journal:  J Biol Chem       Date:  2011-10-10       Impact factor: 5.157

7.  An open-label, single-arm, phase 2 trial of the Polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer.

Authors:  Walter M Stadler; David J Vaughn; Guru Sonpavde; Nicholas J Vogelzang; Scott T Tagawa; Daniel P Petrylak; Peter Rosen; Chia-Chi Lin; John Mahoney; Sanjiv Modi; Peter Lee; Marc S Ernstoff; Wu-Chou Su; Alexander Spira; Korinna Pilz; Richard Vinisko; Charles Schloss; Holger Fritsch; Charles Zhao; Michael A Carducci
Journal:  Cancer       Date:  2013-12-11       Impact factor: 6.860

8.  Kinome-wide functional screen identifies role of PLK1 in hormone-independent, ER-positive breast cancer.

Authors:  Neil E Bhola; Valerie M Jansen; Sangeeta Bafna; Jennifer M Giltnane; Justin M Balko; Mónica V Estrada; Ingrid Meszoely; Ingrid Mayer; Vandana Abramson; Fei Ye; Melinda Sanders; Teresa C Dugger; Eliezer V Allen; Carlos L Arteaga
Journal:  Cancer Res       Date:  2014-12-05       Impact factor: 12.701

9.  Functional genomic screens identify CINP as a genome maintenance protein.

Authors:  Courtney A Lovejoy; Xin Xu; Carol E Bansbach; Gloria G Glick; Runxiang Zhao; Fei Ye; Bianca M Sirbu; Laura C Titus; Yu Shyr; David Cortez
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-04       Impact factor: 11.205

Review 10.  Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications.

Authors:  Ion Cristóbal; Federico Rojo; Juan Madoz-Gúrpide; Jesús García-Foncillas
Journal:  Mol Cell Biol       Date:  2016-05-31       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.